[1]廖鸿钊,钟建辉.氯氮平联合阿立哌唑、利培酮治疗难治性精神分裂症的疗效及对患者糖脂代谢水平的影响[J].医学信息,2022,35(09):141-143.[doi:10.3969/j.issn.1006-1959.2022.09.035]
　LIAO Hong-zhao,ZHONG Jian-hui.Clinical Efficacy of Clozapine Combined with Aripiprazole and Risperidone in the Treatment of Treatment Resistant Sehizophrenia and its Effect on Glucose and Lipid Metabolism[J].Medical Information,2022,35(09):141-143.[doi:10.3969/j.issn.1006-1959.2022.09.035]
点击复制

氯氮平联合阿立哌唑、利培酮治疗难治性精神分裂症的疗效及对患者糖脂代谢水平的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年09期
页码:
141-143
栏目:
论著
出版日期:
2022-05-01

文章信息/Info

Title:
Clinical Efficacy of Clozapine Combined with Aripiprazole and Risperidone in the Treatment of Treatment Resistant Sehizophrenia and its Effect on Glucose and Lipid Metabolism
文章编号:
1006-1959（2022）09-0141-03
作者:
廖鸿钊; 钟建辉
（兴国县第二医院精神科，江西 兴国 342400）
Author(s):
LIAO Hong-zhao; ZHONG Jian-hui
(Department of Psychiatry,Xingguo County Second Hospital,Xingguo 342400,Jiangxi,China)
关键词:
氯氮平; 阿立哌唑; 利培酮; 难治性精神分裂症; 糖脂代谢
Keywords:
Clozapine; Aripiprazole; Risperidone; Treatment resistant sehizophrenia; Glucose and lipid metabolism
分类号:
R749.05
DOI:
10.3969/j.issn.1006-1959.2022.09.035
文献标志码:
A
摘要:
目的 观察氯氮平联合阿立哌唑、利培酮治疗难治性精神分裂症的临床疗效对比及对患者糖脂代谢水平的影响。方法 选取2019年5月-2020年5月在我院诊治的46例难治性精神分裂症患者为研究对象，采用随机数字表法分为对照组和观察组，各23例。对照组采用氯氮平联合利培酮治疗，观察组采用氯氮平联合阿立哌唑治疗，比较两组治疗总有效率、阳性症状与阴性症状评分（PANSS）、认知功能评分、空腹血糖、餐后2h血糖、血脂指标、不良反应发生率。结果 观察组治疗总有效率为91.30%，高于对照组的82.61%（P＜0.05）；两组PANSS评分均低于治疗前，且观察组低于对照组（P＜0.05）；两组认知功能评分均高于治疗前，且观察组高于对照组（P＜0.05）；两组空腹血糖、餐后2h血糖均高于治疗前，但观察组低于对照组（P＜0.05）；两组血清总胆固醇（TC）与三酰甘油（TG）均高于治疗前，但观察组低于对照组（P＜0.05）；观察组不良反应发生率为8.70%，低于对照组的21.74%（P＜0.05）。结论 氯氮平联合阿立哌唑难治性精神分裂症的临床疗效理想，总有效率高，可降低阳性症状与阴性症状评分，提高认知功能评分，且对糖脂代谢指标影响较小，不良反应少。
Abstract:
Objective To observe the clinical efficacy of clozapine combined with aripiprazole and risperidone in the treatment of treatment resistant sehizophrenia and its effect on glucose and lipid metabolism.Methods A total of 46 patients with treatment resistant sehizophrenia treated in our hospital from May 2019 to May 2020 were selected and randomly divided into control group and observation group, with 23 cases in each group. The control group was treated with clozapine combined with risperidone, and the observation group was treated with clozapine combined with aripiprazole. The total effective rate, positive and negative symptom score (PANSS), cognitive function score, fasting blood glucose, postprandial 2 h blood glucose, blood lipid index and incidence of adverse reactions were compared between the two groups.Results The total effective rate of the observation group was 91.30%, which was higher than 82.61% of the control group (P<0.05). The PANSS scores of the two groups were lower than those before treatment, and the observation group was lower than the control group (P<0.05). The cognitive function scores of the two groups were higher than those before treatment, and the observation group was higher than the control group (P<0.05). The fasting blood glucose and postprandial 2 h blood glucose in the two groups were higher than those before treatment, but those in the observation group were lower than those in the control group (P<0.05). The serum total cholesterol (TC) and triglyceride (TG) in the two groups were higher than those before treatment, but the observation group was lower than the control group (P<0.05). The incidence of adverse reactions in the observation group was 8.70%, which was lower than 21.74% in the control group (P<0.05).Conclusion The clinical efficacy of clozapine combined with aripiprazole in treatment resistant sehizophrenia is ideal, and the total effective rate is high. It can reduce the scores of positive and negative symptoms, and improve the cognitive function score. It has little effect on glucose and lipid metabolism indexes, and few adverse reactions.

参考文献/References:

[1]谢渭根,张烈,陶涛.阿立哌唑联合氯氮平治疗难治性精神分裂症患者疗效观察[J].浙江中西医结合杂志,2017,27(7):579-581.[2]杨卫华.阿立哌唑联合音乐疗法治疗精神分裂症的疗效及对患者生活质量的影响[J].中华全科医学,2016,14(2):261-263.[3]郝尚雄,刘伟基.阿立哌唑联合小剂量氯氮平治疗难治性精神分裂症的临床观察[J].中国药物与临床,2015,15(9):1342-1344.[4]张玖龙.氨磺必利与利培酮对女性首发精神分裂症患者认知功能的疗效[J].四川精神卫生,2016,29(6):530-533.[5]李轶琛,马筠,徐汉明,等.阿立哌唑联合治疗对奥氮平治疗后体重增加的精神分裂症患者脂联素和瘦素水平影响[J].中国神经精神疾病杂志,2016,42(7):410-414.[6]肖鹏,孙晓花.阿立哌唑联合氯氮平对精神分裂症患者糖脂代谢与睡眠及体重的影响[J].中国临床药理学杂志,2016,32(13):1178-1181.[7]Citrome L.Aripiprazole long-acting injectable formulations for schizo- phrenia: aripiprazole monohydrate and aripiprazole lauroxil[J].Expert Review of Clinical Pharmacology,2016,9(2):169-186.[8]周波,冯杰.利培酮联合阿立哌唑对慢性精神分裂症患者认知功能及社会功能的影响[J].医学临床研究,2019,36(8):1533-1535.[9]解凯,李德重,刘树林,等.利培酮与氯氮平合并哌罗匹隆应用于难治性精神分裂症的疗效对比分析[J].国际精神病学杂志,2019,46(3):454-456.[10]吴兴曲,贾婷,禹晓东,等.氯氮平联合阿立哌唑治疗难治性精神分裂症的临床效果及对糖脂代谢和胰岛素抵抗的影响[J].解放军医药杂志,2019,31(10):71-75.[11]马秀虎.利培酮与氯氮平合并哌罗匹隆治疗难治性精神分裂症的疗效观察[J].精神医学杂志,2018,31(2):136-138.[12]刘群,张琦.氯氮平联合阿立哌唑、利培酮对首发精神分裂症患者疗效、血清心肌酶谱、IL-13及TNF-α的影响[J].检验医学与临床,2019,16(19):2844-2847.[13]翟媛媛,敖磊,党伟,等.氯氮平联合阿立哌唑、利培酮治疗难治性精神分裂症的临床疗效对比及对患者糖脂代谢水平的影响[J].国际精神病学杂志,2018,45(6):1005-1007.[14]王志满,陈薇,贺英,等.绘画心理技术训练辅助抗精神病药物对精神分裂症康复期患者恢复效果的影响[J].中国医师杂志,2020,22(11):1677-1680,1685.[15]张苏霞,史俊研,叶锋华,等.哌罗匹隆与利培酮改善精神分裂症症状和认知功能的对照研究[J].中国药物与临床,2016,16(12):1788-1789.[16]廖恒,余姝,黄智,等.阿立哌唑与利培酮治疗难治性精神分裂症的临床疗效对比[J].现代生物医学进展,2016,16(12):2333-2335,2299.[17]程伟.阿立哌唑联合利培酮治疗难治性精神分裂症临床对照研究[J].中国药业,2017,26(7):59-61.[18]Suzuki H,Sekiguchi G.Influence of aripiprazole once monthly on clinical symptoms and cognitive function in two schizophrenia patients: Preliminary results[J].Psychiatry Clin Neurosci,2016,70(1):71-72.[19]罗毅,诸秉根,杜洁.利培酮与阿立哌唑治疗精神分裂症的疗效与安全性对比[J].现代仪器与医疗,2016,21(6):110-112.[20]周聪,鄢传东,王鹏.氯氮平与阿立哌唑治疗精神分裂症的疗效及对肝功能的影响[J].中华实用诊断与治疗杂志,2020,34(5):517-519.

相似文献/References:

[1]吴金丽.阿立哌唑的临床应用[J].医学信息,2018,31(14):42.[doi:10.3969/j.issn.1006-1959.2018.14.014]
　WU Jin-li.Clinical Application of Aripiprazole[J].Medical Information,2018,31(09):42.[doi:10.3969/j.issn.1006-1959.2018.14.014]
[2]孙 莹,王惠萍,段丽芬,等.小儿智力糖浆联合阿立哌唑治疗儿童抽动障碍的疗效及其对免疫功能的影响[J].医学信息,2019,32(20):139.[doi:10.3969/j.issn.1006-1959.2019.20.043]
　SUN Ying,WANG Hui-ping,DUAN Li-fen,et al.Therapeutic Effect of Pediatric Intellectual Syrup Combined with Aripiprazole on Children with Tic Disorder and its Effect on Immune Function[J].Medical Information,2019,32(09):139.[doi:10.3969/j.issn.1006-1959.2019.20.043]
[3]孙来顺.精神分裂症的药物治疗[J].医学信息,2021,34(21):42.[doi:10.3969/j.issn.1006-1959.2021.21.010]
　SUN Lai-shun.Drug Treatment of Schizophrenia[J].Medical Information,2021,34(09):42.[doi:10.3969/j.issn.1006-1959.2021.21.010]
[4]黄美英,符 奇.奥氮平与阿立哌唑治疗首发精神分裂症的效果及其对患者认知功能的影响[J].医学信息,2020,33(21):149.[doi:10.3969/j.issn.1006-1959.2020.21.046]
　HUANG Mei-ying,FU Qi.The Effect of Olanzapine and Aripiprazole in the Treatment of First-episode Schizophrenia and Its Influence on Patients’ Cognitive Function[J].Medical Information,2020,33(09):149.[doi:10.3969/j.issn.1006-1959.2020.21.046]
[5]王 震.氯氮平与氯丙嗪治疗维持期精神分裂症患者的临床疗效及安全性比较[J].医学信息,2023,36(03):152.[doi:10.3969/j.issn.1006-1959.2023.03.032]
　WANG Zhen.Comparison of Clinical Efficacy and Safety of Clozapine and Chlorpromazine in the Treatment of Patients with Maintenance Schizophrenia[J].Medical Information,2023,36(09):152.[doi:10.3969/j.issn.1006-1959.2023.03.032]
[6]李书元.氟西汀联合阿立哌唑治疗抑郁症的临床效果及对患者睡眠质量的影响[J].医学信息,2024,37(02):124.[doi:10.3969/j.issn.1006-1959.2024.02.024]
　LI Shu-yuan.Clinical Effect of Fluoxetine Combined with Aripiprazole in the Treatment of Depression and its Effect on Sleep Quality[J].Medical Information,2024,37(09):124.[doi:10.3969/j.issn.1006-1959.2024.02.024]
[7]郝剑辉,崔红兵,郭娅慧.阿立哌唑合并氯氮平治疗难治性精神分裂症的疗效[J].医学信息,2020,33(03):144.[doi:10.3969/j.issn.1006-1959.2020.03.046]
　HAO Jian-hui,CUI Hong-bing,GUO Ya-hui.Effect of Aripiprazole Combined with Clozapine in the Treatment of Refractory Schizophrenia[J].Medical Information,2020,33(09):144.[doi:10.3969/j.issn.1006-1959.2020.03.046]

更新日期/Last Update: 1900-01-01